Evidence map›Paper›PMID 41180199›Full record

ArticleFrontiers in endocrinology2025

Metabolic dysfunction-associated steatotic liver disease attenuates the predictive value of the triglyceride-glucose index for carotid plaque: evidence of insulin resistance-independent pathways.

Fang Zhang, Zheng Wang, Han Zhang, Yu-Qiang Zuo

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fang ZhangDepartment of Endocrine, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Zheng WangDepartment of Respiratory, the Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Han ZhangDepartment of Physical Examination Center, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Yu-Qiang ZuoDepartment of Physical Examination Center, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Insulin resistance (IR), a key driver of atherosclerosis, is associated with cardiovascular risks such as carotid plaque formation. While the triglyceride-glucose (TyG) index has been established as a reliable surrogate marker of IR, its association with carotid plaque formation in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) remains to be explored. Purpose: The study investigated whether MASLD modified the association between the TyG index and carotid plaque, hypothesizing that MASLD-specific metabolic pathways attenuate the association between the TyG index and carotid plaque. Methods: A cross-sectional study was conducted in 3414 participants who were stratified into MASLD (n=796) and non-MASLD (n=2618) groups. MASLD was diagnosed by ultrasonography. The TyG index was calculated and its correlation with carotid plaque was evaluated by multivariable logistic regression adjusting for age, sex, body mass index, waist circumference, and metabolic factors. The interaction effects between the TyG index and MASLD status on carotid plaque prediction were evaluated. Receiver operating characteristic analysis compared the discriminatory ability of the TyG index across subgroups. Results: In the total cohort, a higher TyG index showed a borderline non-significant association with carotid plaque after comprehensive adjustment for covariates including waist circumference (OR: 1.254, 95% CI: 0.985-1.596; Conclusion: MASLD weakened the association between the TyG index and carotid plaque, suggesting that the underlying pathophysiology may involve mechanisms that alter or decouple the relationship between IR and atherosclerosis.

Indexed as

Blood GlucoseCarotid Artery DiseasesFatty LiverInsulin ResistancePlaque, AtheroscleroticTriglyceridesAgedBiomarkersCross-Sectional StudiesFemaleHumansMaleMiddle AgedPredictive Value of TestsBiomarkersBlood GlucoseTriglyceridescarotid plaqueeffect modificationinsulin resistanceMASLDTyG index

Identifiers

PMID41180199
PMCPMC12571656

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.